SpyGlass Pharma, Inc.
Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $31.44
- 52-Week Range
- $17.06 – $39.92
- Market Cap
- $993.14M
- P/E (TTM)
- —
- EPS (TTM)
- -2.70
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 4.72
- PEG Ratio
- —
- Return on Equity
- -43.01%
- Return on Assets
- -27.33%
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Profit Margin
- 0.00%
- Current Ratio
- 15.24
- Debt/Equity
- 0.01
- Total Debt
- $1.61M
- Free Cash Flow
- $-37.95M
- Revenue Growth
- —
- Earnings Growth
- —
- Enterprise Value
- $778.99M
Market Snapshot
About
SpyGlass Pharma, Inc. is a biopharmaceutical company developing treatments for gastrointestinal diseases. The company focuses on novel therapeutic candidates for conditions affecting the digestive system. SpyGlass is working to advance its pipeline through clinical development.